BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32871777)

  • 1. High Paip1 Expression as a Potential Prognostic Marker in Hepatocellular Carcinoma.
    Kim H; Jung W; Kim A; Kim HK; Kim BH
    In Vivo; 2020; 34(5):2491-2497. PubMed ID: 32871777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paip1 affects breast cancer cell growth and represents a novel prognostic biomarker.
    Piao J; Chen L; Jin T; Xu M; Quan C; Lin Z
    Hum Pathol; 2018 Mar; 73():33-40. PubMed ID: 29258905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of PAIP1 on the metastatic potential and prognostic significance in oral squamous cell carcinoma.
    Swarup N; Hong KO; Chawla K; Choi SJ; Shin JA; Oh KY; Yoon HJ; Lee JI; Cho SD; Hong SD
    Int J Oral Sci; 2022 Feb; 14(1):9. PubMed ID: 35153296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of expression of Myc-induced nuclear antigen 53 in hepatocellular carcinoma and its relationship with patient prognosis].
    Ye DX; Zhou X; Yang Q; Hu XY; Li H; Xiang FG
    Zhonghua Gan Zang Bing Za Zhi; 2020 Mar; 28(3):259-265. PubMed ID: 32306660
    [No Abstract]   [Full Text] [Related]  

  • 6. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of FEN1 Is Associated with the Tumor Progression and Prognosis of Hepatocellular Carcinoma.
    Zhang Y; Liu X; Liu L; Chen J; Hu Q; Shen S; Zhou Y; Chen S; Xue C; Cui G; Yu Z
    Dis Markers; 2020; 2020():2514090. PubMed ID: 32399086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revealing the clinical significance and prognostic value of small nucleolar RNA SNORD31 in hepatocellular carcinoma.
    Ding Y; Sun Z; Zhang S; Xu Q; Zhou L; Zhou D; Li Y; Han X; Xu H; Bai Y; Xu C; Ding H; Ge Y; Wang W
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32697317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
    Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
    BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. eIF4A1 Is a Prognostic Marker and Actionable Target in Human Hepatocellular Carcinoma.
    Steinmann SM; Sánchez-Martín A; Tanzer E; Cigliano A; Pes GM; Simile MM; Desaubry L; Marin JJG; Evert M; Calvisi DF
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Kindlin-1 in human hepatocellular carcinoma and its prognostic significance.
    Ma HX; Shu QH; Pan JJ; Liu D; Xu GL; Li JS; Ma JL; Jia WD; Yv JH; Ge YS
    Tumour Biol; 2015 Jun; 36(6):4235-41. PubMed ID: 25592379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low expression of long noncoding RNA CTC-297N7.9 predicts poor prognosis in patients with hepatocellular carcinoma.
    Zhu S; Huang X; Zhang K; Tan W; Lin Z; He Q; Chen Y; Shang C
    Cancer Med; 2019 Dec; 8(18):7679-7692. PubMed ID: 31674731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosome-transmitted long non-coding RNA
    Wang J; Pu J; Zhang Y; Yao T; Luo Z; Li W; Xu G; Liu J; Wei W; Deng Y
    Aging (Albany NY); 2020 Jun; 12(12):11550-11567. PubMed ID: 32602848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma.
    Zeng YL; Guo ZY; Su HZ; Zhong FD; Jiang KQ; Yuan GD
    World J Gastroenterol; 2019 Dec; 25(48):6902-6915. PubMed ID: 31908394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
    Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
    BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of PARPBP Correlates with Tumor Progression and Poor Prognosis in Hepatocellular Carcinoma.
    Yu B; Ding Y; Liao X; Wang C; Wang B; Chen X
    Dig Dis Sci; 2019 Oct; 64(10):2878-2892. PubMed ID: 30949905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of long non-coding RNA GAS5-AS1 and its prognostic and diagnostic significance in hepatocellular carcinoma.
    Wang Y; Jing W; Ma W; Liang C; Chai H; Tu J
    Cancer Biomark; 2018; 22(2):227-236. PubMed ID: 29660898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non‑coding RNA‑based risk scoring system predicts prognosis of alcohol‑related hepatocellular carcinoma.
    Luo Y; Ye J; Wei J; Zhang J; Li Y
    Mol Med Rep; 2020 Aug; 22(2):997-1007. PubMed ID: 32468063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paip1 Indicated Poor Prognosis in Cervical Cancer and Promoted Cervical Carcinogenesis.
    Li N; Piao J; Wang X; Kim KY; Bae JY; Ren X; Lin Z
    Cancer Res Treat; 2019 Oct; 51(4):1653-1665. PubMed ID: 31010277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrator complex subunit 6 (INTS6) inhibits hepatocellular carcinoma growth by Wnt pathway and serve as a prognostic marker.
    Lui KY; Zhao H; Qiu C; Li C; Zhang Z; Peng H; Fu R; Chen HA; Lu MQ
    BMC Cancer; 2017 Sep; 17(1):644. PubMed ID: 28899352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.